DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
about
Influenza prevention and treatment in transplant recipients and immunocompromised hostsInfluenza antivirals currently in late-phase clinical trial.Advances in antivirals for non-influenza respiratory virus infections.DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilationPhase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults.DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantationParainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcomeClinical pharmacokinetics of inhaled antimicrobials.Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients.Parainfluenza 3 Infections Early After Kidney or Simultaneous Pancreas-Kidney Transplantation.Parainfluenza Virus in the Hospitalized Adult.Parainfluenza Virus 3-Specific T Cells: Opportunity for Intervention?Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children.Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management.Novel antiviral agents for respiratory viral infection in immunocompromised adults.
P2860
Q27011595-8FDD8853-3056-4C88-B3E2-0C3F70C0234DQ30398099-6504D332-5584-4254-BEA9-EB37EA307C22Q30457132-49898B5B-63F4-49F7-94BF-380D9426EA93Q35749971-6EB8BF3A-C9F3-467A-8936-B2F1DEC0985CQ36264874-D6D390CA-F059-43D4-B5B0-E3DEBC90B823Q36568965-12D70AC8-5434-406E-BE0C-58B6F7243FF8Q36965855-4525F0F3-8F53-4A63-AB33-F7D3E9C733ECQ37726073-1311A1C2-8799-48E1-AAAA-069E257CCFC4Q38367260-717664B4-3ECE-4A40-A60F-B8DC99174AB9Q38829076-923A871F-5BB5-489D-91DE-AFB4A9F893AAQ39152726-9164B9C2-FD5C-4958-BF44-224B2BF6D5B2Q40168808-D7BA4D5B-8187-4FD5-8EAF-A1D62AE83221Q40215133-D09DC9C3-D12F-480F-83AF-05BD31738958Q41103203-1FC88106-51BE-4093-8A73-7D9FCDFE4AB6Q41873413-03ACADBA-B17D-42E7-8D50-87AC8971177EQ41927260-0F92A06D-2952-4E9B-8EA9-96B4A95D59BAQ42243405-5A964A79-4FFB-47D9-B288-566FD27CBE8F
P2860
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
@en
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
@nl
type
label
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
@en
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
@nl
prefLabel
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
@en
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
@nl
P2093
P2860
P356
P1476
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient.
@en
P2093
A P Limaye
J D Edelman
R L Sanders
R M Rakita
P2860
P304
P356
10.1111/TID.12045
P577
2012-12-26T00:00:00Z